j3PxhGFoAsN97Bsyv4BtkmuyZcSKomDzWMfIC4OXtHUVmJKeCTUAJ8zV2hXM
Current position: Home >> Scientific Research >> Paper Publications

Structure-Based Design of 2-Aminopurine Derivatives as CDK2 Inhibitors for Triple-Negative Breast Cancer

Hits:

Institution:药学院

Title of Paper:Structure-Based Design of 2-Aminopurine Derivatives as CDK2 Inhibitors for Triple-Negative Breast Cancer

Journal:FRONT PHARMACOL

Key Words:anticancer;CDK2 inhibitor;purine;structure-based drug design;triple-negative breast cancer

First Author:梁翰之

Document Code:1539149221204123650

Volume:13

Page Number:864342

Number of Words:20

Translation or Not:No

Date of Publication:2022-05

Release Time:2022-11-11

Prev One:PTPRO is a therapeutic target and correlated with immune infiltrates in pancreatic cancer

Next One:Boronate-Based Fluorescent Probes as a Prominent Tool for H2 O2 Sensing and Recognition